A broad multi-program approach to rapidly identify and develop novel therapeutics and diagnostics for Covid-19 using Bicyclic Peptides (Bicycles)

自行车是一种新型药物，可以使用我们独特的平台技术快速识别，如果它们可以被开发成用于应对当前和/或未来covid大流行的新型抗病毒药物，那么它们就具有实用性。它们也有可能成为新型抗炎疗法，专门针对在医院环境中继续发展为严重炎症的晚期Covid-19患者的需求。在此应用中，我们提出了一种多靶点策略，以确定治疗正在进行的和潜在的未来流行病的新疗法。

Bicycles are a new class of drug that can rapidly be identified using our unique platform technology and have utility if they can be developed as novel anti-virals for use in tackling the current and/or future covid pandemics. They also have potential as novel anti-inflammatory therapies tailored to the requirements of later stage Covid-19 disease sufferers that go on to develop severe inflammatory conditions in the hospital setting. In this application we propose a multi-target strategy to identify novel therapies to treat the ongoing, and potentially future, pandemics.